THTX logo

Theratechnologies Inc. Common


THTX: Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.


Show THTX Financials

Consumer Interest
SEC Filings

Recent trades of THTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by THTX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Peptide compounds derived from melanotransferrin and uses thereof May. 10, 2016
  • Patent Title: Formulations of growth hormone releasing factor (grf) molecules with improved stability Oct. 28, 2014
  • Patent Title: Bifunctional hormone having alpha-msh activity and natriuretic peptide activity and uses thereof Sep. 02, 2014
  • Patent Title: Gh secretagogues and uses thereof Jul. 09, 2013
  • Patent Title: Gh secretagogues and uses thereof May. 07, 2013
  • Patent Title: Growth hormone releasing factor (grf) analogs and uses thereof Jan. 29, 2013
  • Patent Title: Gh secretagogues and uses thereof Nov. 20, 2012

Number of mentions of THTX in WallStreetBets Daily Discussion


Recent insights relating to THTX

CNBC Recommendations

Recent picks made for THTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in THTX

Corporate Flights

Flights by private jets registered to THTX